Peer-reviewedCC BYBiomedicines
Genetically Proxied SGLT2 Inhibition and Risk of Epilepsy: A Mediation Mendelian Randomization Study of Circulating Metabolites
Related
- Genetically Predicted Circulating Lipid Traits and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study
- Genetically predicted GLP-1R expression and idiopathic pulmonary fibrosis: A Mendelian randomization mediation study of JAKMIP3 and pulmonary function
- Circulating 16 micronutrients concentration and risk of abdominal aortic aneurysm: a two-sample mediation Mendelian randomization analysis.
- Identification of genetically supported candidate therapeutic targets for angina pectoris using mendelian randomization
- Abdominal Adiposity and Lacunar Stroke: A Mendelian Randomization Mediation Study
BibTeX
@article{anon2026genetically,
title = {{Genetically Proxied SGLT2 Inhibition and Risk of Epilepsy: A Mediation Mendelian Randomization Study of Circulating Metabolites}},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702378},
note = {CC BY},
}
RIS
TY - JOUR
TI - Genetically Proxied SGLT2 Inhibition and Risk of Epilepsy: A Mediation Mendelian Randomization Study of Circulating Metabolites
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702378
SN - 2227-9059
ER -